Relative Strength Chart NFL Biosciences

Stocks

Real-time Euronext Paris Other stock markets 10:18:06 2026-08-03 EDT			5-day change	1st Jan Change
0.8790 ^EUR	+1.03%		+4.89%	-25.30%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

End-of-day quotes

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	NFL BIOSCIENCES	Bio Therapeutic Drugs	+1.03%	+4.89%	-25.30%	-34.81%	-74.12%	12.68M